201 related articles for article (PubMed ID: 17679209)
1. [Usefulness of 18F-FDG-PET in breast cancer imaging].
Tayama K; Toh U; Fujii T; Shirouzu K; Kaida Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():373-8. PubMed ID: 17679209
[No Abstract] [Full Text] [Related]
2. Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
Eubank WB
Radiol Clin North Am; 2007 Jul; 45(4):659-67, vi. PubMed ID: 17706530
[TBL] [Abstract][Full Text] [Related]
3. [Early prediction of response to primary chemotherapy by sequential FDG -PET in patients with advanced breast cancer].
Momiyama N; Ishikawa T; Ichikawa Y; Shimada H; Katayama A; Ozawa Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():385-8. PubMed ID: 17679210
[No Abstract] [Full Text] [Related]
4. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
5. [FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
Koga S; Nakano S; Honma Y; Ogasawara N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():379-84. PubMed ID: 17682181
[No Abstract] [Full Text] [Related]
6. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
7. Oncological applications of FDG PET imaging.
Delbeke D
J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
[No Abstract] [Full Text] [Related]
8. PET imaging in breast cancer.
Bombardieri E; Crippa F
Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
[TBL] [Abstract][Full Text] [Related]
9. PET/CT Imaging for Monitoring Recurrence and Evaluating Response to Treatment in Breast Cancer.
Lei L; Wang X; Chen Z
Adv Clin Exp Med; 2016; 25(2):377-82. PubMed ID: 27627573
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET in detecting primary breast cancer.
Kumar R; Lal N; Alavi A
J Nucl Med; 2007 Oct; 48(10):1751; author reply 1752. PubMed ID: 17909261
[No Abstract] [Full Text] [Related]
11. FDG-PET and beyond: molecular breast cancer imaging.
Quon A; Gambhir SS
J Clin Oncol; 2005 Mar; 23(8):1664-73. PubMed ID: 15755974
[No Abstract] [Full Text] [Related]
12. [Usefulness of 18F-FDG PET in the diagnosis for breast cancer patients].
Suzuki T; Uno K; Kubo A
Nihon Rinsho; 2006 Mar; 64(3):504-10. PubMed ID: 16529042
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
[TBL] [Abstract][Full Text] [Related]
14. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
Landheer ML; Steffens MG; Klinkenbijl JH; Westenberg AH; Oyen WJ
Br J Surg; 2005 Nov; 92(11):1363-7. PubMed ID: 16187254
[TBL] [Abstract][Full Text] [Related]
15. Evolving role of positron emission tomography in breast cancer imaging.
Eubank WB; Mankoff DA
Semin Nucl Med; 2005 Apr; 35(2):84-99. PubMed ID: 15765372
[TBL] [Abstract][Full Text] [Related]
16. Should FDG PET/CT be used for the initial staging of breast cancer?
Groheux D; Hindié E; Rubello D; Espié M; Baillet G; Giacchetti S; Misset JL; Moretti JL
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1539-42. PubMed ID: 19449002
[No Abstract] [Full Text] [Related]
17. Fluorodeoxyglucose-PET in the management of breast cancer.
Kumar R; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1113-22, ix. PubMed ID: 15488561
[TBL] [Abstract][Full Text] [Related]
18. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer (Br J Surg 2005; 92: 1363-1367).
Hayanga AJ
Br J Surg; 2006 Feb; 93(2):252; author reply 252-3. PubMed ID: 16432827
[No Abstract] [Full Text] [Related]
19. [Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].
Li D; Chen JH; Wang J; Ling R; Yao Q; Wang L
Ai Zheng; 2007 Aug; 26(8):900-4. PubMed ID: 17697556
[TBL] [Abstract][Full Text] [Related]
20. Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.
Cachin F; Prince HM; Hogg A; Ware RE; Hicks RJ
J Clin Oncol; 2006 Jul; 24(19):3026-31. PubMed ID: 16717291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
